Oral methylthioadenosine administration attenuates fibrosis and chronic liver disease progression in Mdr2-/- mice.

Oral methylthioadenosine administration attenuates fibrosis and chronic liver disease progression in Mdr2-/- mice.

<h4>Background</h4>Inflammation and fibrogenesis are directly related to chronic liver disease progression, including hepatocellular carcinoma (HCC) development. Currently there are few therapeutic options available to inhibit liver fibrosis. We have evaluated the hepatoprotective and an...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: M Ujue Latasa, Carmen Gil-Puig, Maite G Fernández-Barrena, Carlos M Rodríguez-Ortigosa, Jesús M Banales, Raquel Urtasun, Saioa Goñi, Miriam Méndez, Sara Arcelus, Nerea Juanarena, Juan A Recio, Sophie Lotersztajn, Jesús Prieto, Carmen Berasain, Fernando J Corrales, Jon Lecanda, Matías A Avila
Format: article
Langue:EN
Publié: Public Library of Science (PLoS) 2010
Sujets:
Medicine
R
Science
Q
Accès en ligne:https://doaj.org/article/ea72f5c5f43e4344b69e60e69b24e059
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/ea72f5c5f43e4344b69e60e69b24e059

Documents similaires